ページ3 - 最高のてんかん医師 - トップ96名の医師

イツハク・フリード教授は、世界で最も優れた脳神経外科医であり、神経科学者の一人です。

フリード博士はスタンフォード大学を卒業し、イェール大学（いずれもアメリカ合衆国）でのトレーニングを経ました。

イツハク・フリード教授の専門分野は以下の通りです：

• 子どもと大人に対する高度な脳手術
• てんかんの治療（外科手術を含む）および研究
• 脳深部刺激療法
• 機能的脳マッピング
• てんかんに関連する血管奇形の治療。

フリード教授の科学的発見：

• てんかん発作の性質と発展を研究する革新的アプローチ
• てんかんに起因する言語および記憶障害の回復のための新しい方法
• てんかん患者の管理に関する最新プログラムおよび治療ガイドの策定。

現在、教授はイヒロフ病院（イスラエル）で患者を受け入れ、UCLAのデイヴィッド・ゲフィン・スクール・オブ・メディシンやイェール大学（いずれもアメリカ合衆国）、テルアビブ医療センター（イスラエル）で教鞭をとっています。

Dr. Buse Cagla Ari, MD, is an Associate Professor of Neurology. She specializes in Parkinson’s disease and other movement disorders, headache disorders, sleep disorders, and dementia. She works at Istanbul Medipol University and the Parkinson’s Disease and Movement Disorders Center (PARMER). She previously served as an Assistant Professor at Bahcesehir University.

Her research focuses on Parkinson’s disease biomarkers, cognition, uric acid and cholesterol associations, restless legs syndrome, and complex headaches. This includes a 13-patient case series. She has published 15 international and 4 Turkish papers and 5 book chapters. Her work has 147 citations on Google Scholar (h-index 5) and 91 citations on Web of Science (h-index 5).

She is a member of the International Parkinson and Movement Disorders Society, the International Headache Society, and the Turkish Parkinson’s Disease Society. She serves as a peer reviewer for SAGE Open Medical Case Reports, BMC Neurology, and Parkinsonism & Related Disorders.

Brain and Nerve Surgery

マルセル・ディネの職歴

現在まで10年5ヶ月、2013年6月より

院長

Kplus、St. Lukas クリニック

脳卒中部門およびてんかん学を含む神経内科クリニックの責任者

2年1ヶ月、2011年5月 - 2013年5月

上級医師、研究グループリーダー

テュービンゲン大学病院、ゲルティ臨床脳研究所

6年11ヶ月、2004年6月 - 2011年4月

研修医、上級医師、研究グループリーダー

デュッセルドルフ大学病院、神経内科

完全なプロフィールを閲覧するにはサイトにログインしてください。 

マルセル・ディネの学歴

2年1ヶ月、2011年5月 - 2013年5月

てんかん学

テュービンゲン神経内科大学病院、ゲルティ臨床脳研究所

てんかん学、自己免疫性脳炎、てんかん重積状態、人工多能性幹細胞

6年11ヶ月、2004年6月 - 2011年4月

神経内科学

デュッセルドルフ・ハインリッヒ・ハイネ大学

臨床神経内科学、神経内科集中治療、神経回路網

2年8ヶ月、2001年11月 - 2004年6月

神経科学

ハンブルク分子神経生物学センター（ZMNH）

幹細胞、神経再生

3年5ヶ月、1998年6月 - 2001年10月

神経内科学

RWTH-Aachen

6年8ヶ月、1991年10月 - 1998年5月

医学

RWTH-Aachen

EDUCATION

• Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
•  
• Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
•  
• Training in Regenerative Geriatric Medicine at Nordic University
•  
• Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
•  
• Training in Regenerative Medicine at Nordic University

EXPERIENCE

• Founder of the biotechnological institute “Bioplenum S.A de C.V”
•  
• Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
•  
• Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent

ACCOLADES

• HemoFenix France representative in Mexico and Latin America
•  
• Kimicor Pharma representative at the Italian laboratory in Mexico
•  
• Krebs International, General Director for the company located in Bulgaria
•  
• General Director for Immunotherapy for México A.C. foundation

Specialist in Neurology
Head of the Advanced Neurosciences Unit – Quirónsalud

Professional Experience

Head of the Neurology Service
Hospital Universitario de Torrevieja (2018 – 2021)
Led a multidisciplinary neurology team with a focus on patient-centered care, especially for neurodegenerative disorders.

Head of Neurology Service
Hospital Clínica Benidorm (2017 – 2018)
Oversaw diagnostic and therapeutic services in general neurology, epilepsy, and movement disorders.

Consultant Neurologist
Hospital General Universitario de Alicante (2017 – 2018)
Specialized in inpatient and outpatient neurology services, actively participated in teaching and research.

Consultant Neurologist
Hospital de Manises, Valencia (2016 – 2017)
Focus on epilepsy and complex neurological diagnostics.

General Practitioner
Baghavatula Charitable Trust (BCT), Vishakapatnam, India (2012 – 2016)
Provided healthcare services in underserved rural communities, gaining valuable experience in global medicine.

Education & Training

Medical Degree
Universidad Autónoma de Madrid (UAM) (2005 – 2011)

Neurology Residency (MIR Program)
Hospital General Universitario de Alicante (2012 – 2016)

Postgraduate Studies

Postgraduate Specialization in Movement Disorders
Universidad Oberta de Catalunya (2019 – 2020)

Postgraduate Specialization in Clinical Research
Chair UAM-Abbvie (2020 – ongoing)

Master in Healthcare Management
UDIMA - Universidad a Distancia de Madrid (2020 – ongoing)

Master in Clinical Neurology
Universidad Francisco de Vitoria (2020 – ongoing)

Professional Societies

Member of the Valencian Society of Neurology (SVN)

Member of the Spanish Society of Neurology (SEN)

Scientific Contributions

Publications:

"Creutzfeldt-Jakob Disease – Heidenhain Variant" – Presented at the 66th Meeting of the Spanish Society of Neurology (2015)

"Sleepwalking or Epilepsy?" – Presented at the 39th Annual Meeting of the Spanish Society of Neuropediatrics (2016)

Conferences & Courses:

Epilepsy Hospital Stage Course – Hospital La Princesa, Madrid (2020)

Updates on Parkinson’s Disease and Movement Disorders – Movement Disorder Society, 2019

American Epilepsy Society Annual Meeting – Baltimore, USA (2019)

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Education & Expertise

1996 to 2000 | Dicle University – Medical Education

Professional Experience

2001 to 2006 | Diyarbakır State Hospital – Neurology Specialist

2006 to 2009 | Düzce Atatürk State Hospital – Neurology Specialist

2009 to 2013 | Düzce University – Associate Professor of Neurology

2013 to 2016 | Düzce University – Associate Professor of Neurology

2017 to 2024 | Pendik Private Century Hospital – Associate Professor of Neurology

2024 to Present | VM Medical Park Pendik Hospital – Associate Professor of Neurology

Courses & Certifications

June, 2012 | Trainer Training Course

February, 2010 | Trainer Training Course

March, 2011 | Sleep Medicine Certification Program Preparation Course

December, 2012 | Sleep Disorders Diagnosis and Treatment Course

DBS Application Training and Course – Dubai

Professional Memberships

Turkish Medical Association

Turkish Neurology Association

Turkish Sleep Medicine Association

Awards & Recognitions

2014 | Düzce University Rectorship – Publication Success Incentive Award

Education

2005 – 2011 | Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
M.D. Degree

2013 – 2019 | Erenköy Mental Health and Neurology Training and Research Hospital, Istanbul, Turkey
Neurology Residency Program

Languages

English – Very Advanced

Professional Experience

Artvin Borçka State Hospital, Artvin, Turkey
General Practitioner (Compulsory Service)
2011 – 2012

Erenköy Mental Health and Neurology Training and Research Hospital, Neurology Department, Istanbul, Turkey
Resident Physician
2013 – 2019

Siirt State Hospital, Siirt, Turkey
Neurology Specialist (Compulsory Service)
2019 – March 2021

Private Pendik Medical Park Hospital, Istanbul, Turkey
Neurology Specialist
April 3, 2021 – April 10, 2024

Bahçeşehir University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Assistant Professor
April 19, 2021 – June 1, 2024

Medipol Acıbadem Regional Hospital, Istanbul, Turkey
Associate Professor of Neurology
April 22, 2024 – Present

Istanbul Medipol University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Associate Professor of Neurology
November 11, 2024 – Present

Memberships

Turkish Neurology Society

Turkish Medical Association

International Parkinson and Movement Disorder Society

Turkish Neurology Society Neurorehabilitation Working Group

Global Migraine and Pain Society

International Headache Society

Turkish Parkinson’s Disease Society

Turkish Alzheimer Association, Kadıköy Branch

Areas of Interest

Parkinson’s disease and other movement disorders

Migraine and other headache disorders

Sleep disorders

Dementia and Alzheimer’s disease

EEG, Polysomnography (PSG), Multiple Sleep Latency Test (MSLT)

Botulinum toxin injections for movement disorders

Nerve blocks and botulinum toxin for headache management

Epilepsy

Dr. Fatma Gulhan Sahbaz is a neurologist. She graduated from Manisa Celal Bayar University Faculty of Medicine. She completed her neurology residency at SBÜ Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital. Dr. Sahbaz has served as Clinic Chief at Afyonkarahisar State Hospital. She currently practices at İzmir Ekonomi University Medical Point Hospital.

She treats many neurological conditions, including Alzheimer’s disease, ALS, epilepsy, cerebrovascular diseases, brain tumors, movement disorders, and headaches. Dr. Sahbaz is experienced in advanced treatments such as acute stroke intervention, deep brain stimulation, IVIG therapy, and botulinum toxin injections.

She is a member of the Turkish Neurology Society, International Parkinson and Movement Disorder Society, and European Academy of Neurology.

Education and Expertise

• 1999 – 2005 – FIRAT UNIVERSITY FACULTY OF MEDICINE
• 1995 – 1999 – IZMIR ATATURK HIGH SCHOOL

Diseases

• Alzheimer’s type dementia
• Headaches
• Dizziness
• Cerebrovascular diseases
• Vascular diseases
• Dementia Diseases
• Demyelinating Diseases
• Epilepsy
• Movement Disorders
• Migraine
• Myopathies
• MOGAD

Treatment Methods

• Botox
• Duodopa Treatment
• Intravenous Thrombolytic
• IVIG Treatment
• Migraine vaccine
• Migraine Botox

Experience

• 2005-2010 – Ege University Faculty of Medicine, Department of Neurology, Specialization Student, Izmir.
• 2010-2012 – İzmir Tire State Hospital Neurology Department
• September 2012 – May 2013 – Çanakkale 18 March University, Faculty of Medicine, Department of Neurology, Assistant Professor.
• 2013 – Medical Point Izmir Hospital Neurology Department

Professional Memberships

• Turkish Neurology Association

ウタ・マイディング＝ラマデ教授は、ドイツにおける主要な神経科医の一人であり、インスルト、多発性硬化症、リウマチ性疾患および神経障害の治療に特化しています。

ドクターは1988年にハイデルベルク大学を卒業し、その後、ユニバーシティ・カレッジ・ロンドンとメンフィス大学でポストグラデュエートトレーニングを受けました。

現在、マイディング＝ラマデ教授は：

• ノルトヴェスト・クリニックの神経科部門を率いる
• ウイルス性脳炎のドイツ神経学会を率いる（Deutsche Gesellschaft für Neurologie）。
• ロバート・コッホ研究所でインスルト治療に関する地域アドバイザーをしている。

ドクターは多くの奨学金や賞を受けており、革新的な肺炎治療法に対してブラウン財団賞を含みます。

Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.

Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.

He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).

Neurologist. Head of the Center for Epilepsy

Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

EDUCATION:

2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY

2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES

2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases

2004 DICLE UNIVERSITY, FACULTY OF MEDICINE

EXPERIENCE:

2018 Istanbul Medipol Hospital

2017 - 2018 Kartal Education and Research Hospital

2014 - 2016 Denizli State Hospital

2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital

2006 - 2011 Izmir Tepecik Education and Research Hospital

2011Izmir Education and Research Hospital

• Staff physician, Epilepsy Group, Department of Child Neurology, Hospital Sant Joan de Déu.
• Clinical Research Assistant, Department of Epilepsy, Sleep and Neurofunctional Research in Children.

アレクシス・アズミノグル博士は、30年の経験を持つ小児てんかん専門医です。彼は、児童てんかんの医学的および外科的治療、認知発達障害（知覚、記憶、論理などのあらゆる種類の思考過程）、および病気の局所形態における感情の調整を専門としています。

現在、アズミノグル博士はバルセロナのサンジョアン・デ・デウ小児病院でてんかんプログラムを調整し、リヨン大学病院（フランス）のてんかん、睡眠障害および小児神経生理学ユニットを率いています。

アレクシス・アズミノグルは、てんかんの薬物および外科的治療、小児てんかんの遺伝的特徴、および局所てんかんに関連する脳の障害の分野で臨床研究に関与しています。

科学活動

• 自閉症および神経発達障害専門委員会の会長;
• 国際てんかん対策リーグ（ILAE）からのてんかん大使賞の受賞者;
• フランス、リヨン大学病院での「てんかんおよび気分障害: 新たに診断された子供における前向き縦断研究」研究の主研究者およびコーディネーター;
• 「小児神経学」専門のヨーロッパ神経学アカデミーの科学グループの共同議長;
• 小児てんかんに関する124の科学論文と10冊の本の著者。